Does chocolate reduce blood pressure? A meta-analysis

被引:130
作者
Ried, Karin [1 ]
Sullivan, Thomas [2 ]
Fakler, Peter [1 ]
Frank, Oliver R. [1 ]
Stocks, Nigel P. [1 ]
机构
[1] Univ Adelaide, Discipline Gen Practice, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA 5005, Australia
来源
BMC MEDICINE | 2010年 / 8卷
关键词
RICH DARK CHOCOLATE; RISK-FACTORS; DEPENDENT VASODILATION; ENDOTHELIAL FUNCTION; INSULIN SENSITIVITY; THEOBROMA-CACAO; COCOA FLAVANOLS; NITRIC-OXIDE; HEALTHY; HYPERTENSION;
D O I
10.1186/1741-7015-8-39
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Dark chocolate and flavanol-rich cocoa products have attracted interest as an alternative treatment option for hypertension, a known risk factor for cardiovascular disease. Previous meta-analyses concluded that cocoa-rich foods may reduce blood pressure. Recently, several additional trials have been conducted with conflicting results. Our study summarises current evidence on the effect of flavanol-rich cocoa products on blood pressure in hypertensive and normotensive individuals. Methods: We searched Medline, Cochrane and international trial registries between 1955 and 2009 for randomised controlled trials investigating the effect of cocoa as food or drink compared with placebo on systolic and diastolic blood pressure (SBP/DBP) for a minimum duration of 2 weeks. We conducted random effects meta-analysis of all studies fitting the inclusion criteria, as well as subgroup analysis by baseline blood pressure (hypertensive/normotensive). Meta-regression analysis explored the association between type of treatment, dosage, duration or baseline blood pressure and blood pressure outcome. Statistical significance was set at P < 0.05. Results: Fifteen trial arms of 13 assessed studies met the inclusion criteria. Pooled meta-analysis of all trials revealed a significant blood pressure-reducing effect of cocoa-chocolate compared with control (mean BP change +/- SE: SBP: -3.2 +/- 1.9 mmHg, P = 0.001; DBP: -2.0 +/- 1.3 mmHg, P = 0.003). However, subgroup meta-analysis was significant only for the hypertensive or prehypertensive subgroups (SBP: -5.0 +/- 3.0 mmHg; P = 0.0009; DBP: -2.7 +/- 2.2 mm Hg, P = 0.01), while BP was not significantly reduced in the normotensive subgroups (SBP: -1.6 +/- 2.3 mmHg, P = 0.17; DBP: -1.3 +/- 1.6 mmHg, P = 0.12). Nine trials used chocolate containing 50% to 70% cocoa compared with white chocolate or other cocoa-free controls, while six trials compared high- with low-flavanol cocoa products. Daily flavanol dosages ranged from 30 mg to 1000 mg in the active treatment groups, and interventions ran for 2 to 18 weeks. Meta-regression analysis found study design and type of control to be borderline significant but possibly indirect predictors for blood pressure outcome. Conclusion: Our meta-analysis suggests that dark chocolate is superior to placebo in reducing systolic hypertension or diastolic prehypertension. Flavanol-rich chocolate did not significantly reduce mean blood pressure below 140 mmHg systolic or 80 mmHg diastolic.
引用
收藏
页数:11
相关论文
共 48 条
  • [1] HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity
    Adamson, GE
    Lazarus, SA
    Mitchell, AE
    Prior, RL
    Cao, GH
    Jacobs, PH
    Kremers, BG
    Hammerstone, JF
    Rucker, RB
    Ritter, KA
    Schmitz, HH
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1999, 47 (10) : 4184 - 4188
  • [2] Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol
    Allen, Robin R.
    Carson, LeaAnn
    Kwik-Uribe, Catherine
    Evans, Ellen M.
    Erdman, John W., Jr.
    [J]. JOURNAL OF NUTRITION, 2008, 138 (04) : 725 - 731
  • [3] The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects
    Almoosawi, Suzana
    Fyfe, Lorna
    Ho, Clement
    Al-Dujaili, Emad
    [J]. BRITISH JOURNAL OF NUTRITION, 2010, 103 (06) : 842 - 850
  • [4] [Anonymous], 2008, Review manager (RevMan) [Computer program]. Version 5.0
  • [5] Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients - A double-masked, randomized, controlled trial
    Balzer, Jan
    Rassaf, Tienush
    Heiss, Christian
    Kleinbongard, Petra
    Lauer, Thomas
    Merx, Marc
    Heussen, Nicole
    Gross, Heidrun B.
    Keen, Carl L.
    Schroeter, Hagen
    Kelm, Malte
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (22) : 2141 - 2149
  • [6] OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS
    BEGG, CB
    MAZUMDAR, M
    [J]. BIOMETRICS, 1994, 50 (04) : 1088 - 1101
  • [7] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [8] Cocoa and Cardiovascular Health
    Corti, Roberto
    Flammer, Andreas J.
    Hollenberg, Norman K.
    Luescher, Thomas F.
    [J]. CIRCULATION, 2009, 119 (10) : 1433 - 1441
  • [9] A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults
    Crews, W. David, Jr.
    Harrison, David W.
    Wright, James W.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (04) : 872 - 880
  • [10] Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects
    Davison, K.
    Coates, A. M.
    Buckley, J. D.
    Howe, P. R. C.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (08) : 1289 - 1296